Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy

1. Rivero-Juarez, A.
2. Neukam, K.
3. Labarga, P.
4. Camacho, A.
5. Macias, J.
6. Barreiro, P.
7. Torre-Cisneros, J.
8. Pineda, J.A.
9. Soriano, V.
10. Rivero, A.